Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Levicept Ltd.

Headquarters: Sandwich, United Kingdom
Year Founded: 2012
Status: Private

BioCentury | Aug 14, 2024
Product Development

Clinical Report: Acelyrin shifts priorities; Rivus moving forward in obesity

Plus: Readouts from Avidity, Apellis/Sobi, Levicept and Merck
BioCentury | Dec 1, 2023
Management Tracks

Eliot Forster named Levicept CEO

Plus: Sirnaomics promotes Lebel to CMO and updates from Enavate Sciences, Avoro Ventures, Eagle, Calliditas, 20Med 
BioCentury | Feb 8, 2016
Finance

Asset renaissance

How Medicxi increases Phase II successes with less capital
BioCentury | Oct 13, 2014
Financial News

Levicept completes venture financing

BioCentury | Oct 8, 2014
Financial News

Levicept raises L10M series A

BioCentury | Sep 15, 2014
Emerging Company Profile

Levicept: Modulating NGF

Levicept hopes NGF modulator may be disease modifying in osteoarthritis
BioCentury | Sep 1, 2014
Finance

Nurturing killer seeds

Why Index Nursery plans to publicize wins, failures of VC's killer experiments
Items per page:
1 - 9 of 9